-
公开(公告)号:US20170204149A1
公开(公告)日:2017-07-20
申请号:US15321246
申请日:2015-06-19
IPC分类号: C07K14/495 , C07K14/765
CPC分类号: C07K14/495 , A61K38/00 , C07K14/4756 , C07K14/765 , C07K2319/31
摘要: The disclosure relates to fusion polypeptides comprising serum albumin or a functional variant thereof and GDF15 protein or a functional variant thereof and to pharmaceutical compositions that contain the fusion polypeptides, nucleic acids that encode the fusion polypeptides, methods of making the polypeptides and use of the polypeptides to decreasing appetite, decreasing body weight and treating metabolic diseases.
-
公开(公告)号:US20190135908A1
公开(公告)日:2019-05-09
申请号:US16096579
申请日:2017-04-26
申请人: Hong CHEN , Rajiv CHOPRA , Seung Wan HAHM , Norio HAMAMATSU , Ryan Scott STREEPER , Mei XU , NOVARTIS AG
发明人: Hong CHEN , Rajiv CHOPRA , Seung Wan HAHM , Norio HAMAMATSU , Ryan Scott STREEPER , Mei XU
IPC分类号: C07K16/22
摘要: Provided herein are monoclonal antibodies (e.g., human antibodies) binding to human Growth Differentiation Factor 15 protein (hereinafter, sometimes referred to as “GDF15”), and pharmaceutical compositions and methods of treatment comprising the same.
-